160 related articles for article (PubMed ID: 25394439)
1. Neurocognitive functions and behavioral profiles in children with nephropathic cystinosis.
Aly R; Makar S; El Bakri A; Soliman NA
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1224-31. PubMed ID: 25394439
[TBL] [Abstract][Full Text] [Related]
2. Behavioral profiles of children with infantile nephropathic cystinosis.
Delgado G; Schatz A; Nichols S; Appelbaum M; Trauner D
Dev Med Child Neurol; 2005 Jun; 47(6):403-7. PubMed ID: 15938069
[TBL] [Abstract][Full Text] [Related]
3. Intellectual and motor performance, quality of life and psychosocial adjustment in children with cystinosis.
Ulmer FF; Landolt MA; Vinh RH; Huisman TA; Neuhaus TJ; Latal B; Laube GF
Pediatr Nephrol; 2009 Jul; 24(7):1371-8. PubMed ID: 19294426
[TBL] [Abstract][Full Text] [Related]
4. Visuomotor performance in children with infantile nephropathic cystinosis.
Scarvie KM; Ballantyne AO; Trauner DA
Percept Mot Skills; 1996 Feb; 82(1):67-75. PubMed ID: 8668504
[TBL] [Abstract][Full Text] [Related]
5. Global intellectual deficits in cystinosis.
Williams BL; Schneider JA; Trauner DA
Am J Med Genet; 1994 Jan; 49(1):83-7. PubMed ID: 8172256
[TBL] [Abstract][Full Text] [Related]
6. Cortical atrophy and cognitive performance in infantile nephropathic cystinosis.
Nichols SL; Press GA; Schneider JA; Trauner DA
Pediatr Neurol; 1990; 6(6):379-81. PubMed ID: 2073300
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological and neuroanatomical phenotype in 17 patients with cystinosis.
Curie A; Touil N; Gaillard S; Galanaud D; Leboucq N; Deschênes G; Morin D; Abad F; Luauté J; Bodenan E; Roche L; Acquaviva C; Vianey-Saban C; Cochat P; Cotton F; Bertholet-Thomas A
Orphanet J Rare Dis; 2020 Feb; 15(1):59. PubMed ID: 32102670
[TBL] [Abstract][Full Text] [Related]
8. Specific cognitive deficits in young children with cystinosis: evidence for an early effect of the cystinosin gene on neural function.
Trauner DA; Spilkin AM; Williams J; Babchuck L
J Pediatr; 2007 Aug; 151(2):192-6. PubMed ID: 17643777
[TBL] [Abstract][Full Text] [Related]
9. Neurobehavioral consequences of a genetic metabolic disorder: visual processing deficits in infantile nephropathic cystinosis.
Ballantyne AO; Trauner DA
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Oct; 13(4):254-63. PubMed ID: 11186161
[TBL] [Abstract][Full Text] [Related]
10. Visual and verbal learning in a genetic metabolic disorder.
Spilkin AM; Ballantyne AO; Trauner DA
Neuropsychologia; 2009 Jul; 47(8-9):1883-92. PubMed ID: 19428420
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive functioning in school-aged cystinosis patients.
Besouw MT; Hulstijn-Dirkmaat GM; van der Rijken RE; Cornelissen EA; van Dael CM; Vande Walle J; Lilien MR; Levtchenko EN
J Inherit Metab Dis; 2010 Dec; 33(6):787-93. PubMed ID: 20814825
[TBL] [Abstract][Full Text] [Related]
12. Cognitive development in low risk preterm infants at 3-4 years of life.
Caravale B; Tozzi C; Albino G; Vicari S
Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F474-9. PubMed ID: 15956096
[TBL] [Abstract][Full Text] [Related]
13. Effect of age at treatment on cognitive performance in patients with cystinosis.
Viltz L; Trauner DA
J Pediatr; 2013 Aug; 163(2):489-92. PubMed ID: 23462307
[TBL] [Abstract][Full Text] [Related]
14. Functional outcome at school age of preterm infants with periventricular hemorrhagic infarction.
Roze E; Van Braeckel KN; van der Veere CN; Maathuis CG; Martijn A; Bos AF
Pediatrics; 2009 Jun; 123(6):1493-500. PubMed ID: 19482759
[TBL] [Abstract][Full Text] [Related]
15. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
[TBL] [Abstract][Full Text] [Related]
16. Panayiotopoulos syndrome and Gastaut syndrome are distinct entities in terms of neuropsychological findings.
Akca Kalem S; Elmali AD; Demirbilek V; Oktem O; Yapici Z; Saltik S; Gokcay A; Dervent A; Baykan B
Epilepsy Behav; 2019 Oct; 99():106447. PubMed ID: 31398558
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial.
Mesotten D; Gielen M; Sterken C; Claessens K; Hermans G; Vlasselaers D; Lemiere J; Lagae L; Gewillig M; Eyskens B; Vanhorebeek I; Wouters PJ; Van den Berghe G
JAMA; 2012 Oct; 308(16):1641-50. PubMed ID: 23101118
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
19. Executive function in nephropathic cystinosis.
Ballantyne AO; Spilkin AM; Trauner DA
Cogn Behav Neurol; 2013 Mar; 26(1):14-22. PubMed ID: 23538568
[TBL] [Abstract][Full Text] [Related]
20. Medical and cognitive outcome in children with traumatic brain injury.
Campbell CG; Kuehn SM; Richards PM; Ventureyra E; Hutchison JS
Can J Neurol Sci; 2004 May; 31(2):213-9. PubMed ID: 15198446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
